WMH Contributions to Cognitive Impairment: Rationale and Design of the Diverse VCID Study
Charles DeCarli,Kumar B. Rajan,Lee-Way Jin,Jason Hinman,David K. Johnson,Danielle Harvey,Myriam Fornage,Alexa Beiser,Hector Gonzalez,Walter Kukull,Lisa Barnes,Fanny Elahi,Raina Croff,Joel Kramer,Johannes Weickenmeier,Dana Tudorascu,Marilyn Albert,Suzanne Craft,Gregory Jicha,David A. Wolk,Henry Paulson,James Brewer,Sanjay Asthana,Sudha Seshadri,Adam Brickman,Helena Chang Chui,Amy Nelson,Sean Savitz,Andrew Saykin,David Geldmacher,Arjun Masurkar,Tatjana Rundek,Pauline Maillard,Alex Knaack
DOI: https://doi.org/10.1161/strokeaha.124.045903
IF: 10.17
2024-11-22
Stroke
Abstract:Stroke, Ahead of Print. As awareness of dementia increases, more individuals with minor cognitive complaints are requesting clinical assessment. Neuroimaging studies frequently identify incidental white matter hyperintensities, raising patient concerns about their brain health and future risk for dementia. Moreover, current US demographics indicate that ≈50% of these individuals will be from diverse backgrounds by 2060. Racial and ethnic minority populations bear a disproportionate burden of vascular risk factors magnifying dementia risk. Despite established associations between white matter hyperintensities and cognitive impairment, including dementia, no study has comprehensively and prospectively examined the impact of individual and combined magnetic resonance imaging measures of white matter injury, their risk factors, and comorbidities on cognitive performance among a diverse, nondemented, stroke-free population with cognitive complaints over an extended period of observation. The Diverse VCID (Diverse Vascular Cognitive Impairment and Dementia) study is designed to fill this knowledge gap through 3 assessments of clinical, behavioral, and risk factors; neurocognitive and magnetic resonance imaging measures; fluid biomarkers of Alzheimer disease, vascular inflammation, angiogenesis, and endothelial dysfunction; and measures of genetic risk collected prospectively over a minimum of 3 years in a cohort of 2250 individuals evenly distributed among Americans of Black/African, Latino/Hispanic, and non-Hispanic White backgrounds. The goal of this study is to investigate the basic mechanisms of small vessel cerebrovascular injury, emphasizing clinically relevant assessment tools and developing a risk score that will accurately identify at-risk individuals for possible treatment or clinical therapeutic trials, particularly individuals of diverse backgrounds where vascular risk factors and disease are more prevalent.
peripheral vascular disease,clinical neurology